ArticleJournal of pancreatic cancer2019

A Phase I/II Open-Label Multicenter Single-Arm Study of FABLOx (Metronomic 5-Fluorouracil Plus

Vaibhav Sahai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.